HE4 and eIF3a Expression Correlates with Surgical Outcome and Overall Survival in Ovarian Cancer Patients with Secondary Cytoreduction

For recurrent ovarian cancer (ROC), secondary cytoreductive surgery (SCS) is recommended as one optional treatment. However, little is known about the expression and clinical significance of biomarkers during SCS. Human epididymis protein 4 (HE4) is a clinical biomarker for ovarian cancer. Eukaryoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chen-Hui, Zhao, Min, Chen, Xiao-Yan, Shahabi, Shohreh, Qiang, Wenan, Zeng, Liang, Wang, Jing, Zhou, Hong-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036880/
https://www.ncbi.nlm.nih.gov/pubmed/30026845
http://dx.doi.org/10.7150/jca.25184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036880/
https://www.ncbi.nlm.nih.gov/pubmed/30026845
http://dx.doi.org/10.7150/jca.25184

Ejemplares similares